Market Cap
Merck & Co., Inc.
$296.51 Billion
USD as of Jan. 1, 2024
Company | Market Cap (USD) |
---|---|
Lilly | $586.39 B |
Johnson & Johnson | $387.50 B |
AbbVie | $285.06 B |
Roche | $240.44 B |
Novartis | $220.27 B |
Company | Market Cap (USD) |
---|---|
Lilly | $586.39 B |
UnitedHealth Group | $504.47 B |
Novo Nordisk | $461.52 B |
Johnson & Johnson | $387.50 B |
AbbVie | $285.06 B |
Top 1-year algo backtest: +298.72%
$10,000 in April 2023 would now be $39,872 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Merck & Company, Inc., known as Merck Sharp & Dohme, or MSD, outside the United States and Canada, is one of the largest pharmaceutical companies in the world. Founded in 1891 in the US, and independent since World War I from its parent company, now one of the largest companies in Germany, Merck provides prescription medicines, vaccines, biologic therapies, and animal health products.
Merck & Co., Inc. has the following listings and related stock indices.
Stock: NYSE: MRK
Stock: FSX: 6MK
Stock: Euronext: MRK
The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.